Tag: FDA enforcement

FDA-News (1)

Bad Ad Complaints Yield Two OPDP Warning Letters, One on COVID Email Claims

FDA-News (1)

By One Measure, 2020 OPDP Enforcement Is Off to Slow Start

thermometer-temperature-fever-flu

As COVID-19 Pandemic Continues, Promotion of Unapproved “Cures” Abounds

CHC_FDA-Regulatory Images1

FDA Streamlines COVID-19 Product Pathways, Continues to Crack Down on Misleading Claims

CHC_FDA-Regulatory Images1

FDA and FTC: Coronavirus Products Are Fraudulent, Could Delay Treatment

CHC_FDA-Regulatory Images1

Press Release Highlighting Omission of Risk Warning Letter Closes OPDP’s Enforcement Year

CHC_FDA-Regulatory Images1

Promotion of IND for Brain Cancer Treatment Prompts OPDP Enforcement Letter

CHC_general1

FDA Amps Up Foreign Inspections Under Pressure to Bend on Opposition to Drug Importation

CHC_FDA-Regulatory Images1

OPDP Warning Letter: Omission of Risk Info in DTC Print Ad/Display Banners Misbrands ED Drug